W.R. Berkley Reinsurance & Monoline Excess — Assumed from Other Companies remained flat by 0.0% to $274.19M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $265.30M to $274.19M. Over 4 years (FY 2021 to FY 2025), Reinsurance & Monoline Excess — Assumed from Other Companies shows an upward trend with a 4.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates an expansion of the segment's reinsurance portfolio and its influence in the risk-transfer market.
This represents the premiums received by the segment for taking on risk from other insurance companies. It is a core com...
Standard metric for Assumed Premiums in reinsurance and specialty insurance segments.
wrb_segment_reinsurance_monoline_excess_assumed_from_other_companies| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $918.10M | $993.86M | $1.04B | $1.06B | $1.10B |
| YoY Change | — | +8.3% | +5.1% | +1.6% | +3.4% |